Author: biocytogen

Biocytogen Announces Dr. Zhaoxue (Luke) Yu as Global Head of Preclinical Pharmacology

April 2, 2020

On March 31st, Biocytogen announced Dr. Zhaoxue (Luke) Yu as our Global Head of Preclinical Pharmacology. As our global preclinical pharmacology team leader, Dr. Yu is dedicated to furthering Biocytogen’s innovative antibody discovery platform and serving as our liaison person for strategic partnerships between Biocytogen and external collaborators. Dr. Yu brings more than 15 years […]

Read More

April Webinar: In Vivo vs. In Vitro Therapeutic Antibody Discovery

March 23, 2020

Date: April 16th, 2020 | 11am EST Presenter: Lei Chen,  Ph.D. Senior Director of Antibody Discovery of Biocytogen REGISTER NOW About the webinar in vivo antibody discovery using transgenic/humanized mice is of rising importance for the antibody community as it offers a multitude of benefits over in vitro methods (such as phage display of immune libraries) and humanization […]

Read More

Gene Targeting Service Verified with Industry-leading Quality Control Measures

March 12, 2020

  At Biocytogen, we take pride in our quality control measures when we target and edit genes for our mouse models and drug development endeavors. From preventing potentially disastrous results before they occur to instituting reliable, tried-and-true protocols, proper attention to quality control when gene-editing can save clients both time and resources. For example, based […]

Read More

GEN Magazine Mentions Biocytogen and Its Humanized Mice Model

March 6, 2020

Showcased in GEN Magazine’s March issue, Biocytogen speaks about the current state and imminent future of animal models, specifically on the humanization of mouse models for complex drug development challenges. Senior vice president of Biocytogen and CEO of Biocytogen Boston Qingcong Lin, PhD is featured alongside executives at Charles River Laboratories, Taconic Biosciences, Jackson Laboratory, […]

Read More

Knock In and Knock Out Mice as Powerful Disease Models

March 3, 2020

Why Do We Care About Gene-edited Mice? The generation of knockout and knock-in animal models has allowed not only disease research but also the development of disease-fighting drugs. The Nobel Prize for Physiology and Medicine recognized Evans, Smithies, and Capecchi for their joint effort in creating the first knockout mouse over two decades ago in […]

Read More

Peptalk 2020: The Protein Science Week

January 13, 2020

Location: Hilton San Diego Bayfront, San Diego, CA Dates: January 20-24, 2020 Booth: #424 RenMab™ Mouse: a leading platform for fully human antibody generation Speaker: Benny Yang, Chief Scientific Officer & Director of Antibody Discovery of Biocytogen Time: January 22 at 12:15 pm Track: Lead and Candidate Selection for Therapeutic Proteins Presentation Abstract: Biocytogen has […]

Read More

Nature Research Webcast: Accelerating therapeutic antibody discovery with fully human antibody mice

November 26, 2019

Date: December 10, 2019 Time: 8am PST / 11am EST / 4pm GMT / 5pm CET Register Now Overview: Production of fully human antibody is a critical step in the antibody discovery process. In many cases, hybridoma with genetically modified animals or post-optimization humanization are often employed to generate humanized antibodies. Amid the laborious procedures, some major […]

Read More

The Utility of the Rosa26 Knock-in Mouse

November 19, 2019

The Rosa26 locus in the mouse genome is a “safe harbor” which allows researchers to express genes of interest. Different gene targeting technologies (embryonic stem cells; CRISPR) are used to make specific DNA insertions at the Rosa26 locus. The rationale for scientists to use Rosa26 and other key benefits to using this type of mouse […]

Read More

PEGS Europe 2019

Date: November 18-22, 2019
Location: Lisbon Congress Center, Lisbon, Portugal

Location: Lisbon Congress Center, Lisbon, Portugal Dates: November 18-22, 2019 Booth: #349 RenMab™ Mouse: a leading platform for fully human antibody generation Speaker: Chaoshe Guo, Ph.D., M.D., Vice President & Global Head of Business Development of Biocytogen Time: November 20th, 10:05 – 10:35 Session: Advancing Bispecifics and Combination Therapy to the Clinic Presentation Abstract: Biocytogen […]

Read More

RenMab™ Mouse Featured in GEN Magazine

November 8, 2019

Biocytogen’s RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here.  RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable regions of heavy chain and k light chain are replaced by human counterparts in situ Constant region is retained to ensure proper B […]

Read More

Back to top